News Release

Zogenix to Participate in Morgan Stanley Global Healthcare Conference 2014


SAN DIEGO, Sept. 2, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced that Zogenix management will present at the Morgan Stanley Global Healthcare Conference 2014 in New York, NY on September 10, 2014.

Event: Morgan Stanley Global Healthcare Conference 2014

Date: Wednesday, September 10, 2014

Place: New York City

Time: 10:20 am ET/ 07:20 am PT

The presentation will be webcast live and archived for 30 days on Zogenix' Investor Relations website at Management will also be available to participate in one-on-one meetings at the conference.

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with pain-related conditions and CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.


CONTACT: Investors
         Zack Kubow, The Ruth Group